Home » Students » Alumni » Alumni Page
Home
Director Intro
Structure
Timeline
Med 1 & 2
Grad School
Med 3 & 4
Funding
Directors/Administrators
Committees
Research
Training Programs
Faculty By Name
Faculty By Program
Resources
History
Campus Resources
Students
Research Highlights
Students by Name
Students by Year
Resources
Alumni
By Name
By Degree
By Year
Publications
Admissions
Procedure
Application
Living in Madison
Housing
Dining
Campus Tour
City
Current Events
Seminar
Symposium
Retreat
Contact Us
Alumni Page


Eric Y. Chen    1989-1999
Oncology Fellow
University of Washington, Fred Hutchinson Cancer Research Center

University of Wisconsin - Madison 1989

Human Oncology PhD 1997
Steven Clark
ABL transformation of lymphocyte progenitors
 
The preferential ability of the ABL oncogene to transform immature B-cells in vitro has served as a useful system for studying B-lymphopoiesis. We hypothesized that ABL could be used to establish an analogous system to transform immature T-cells in vitro for studying T-lymphopoiesis; however, we could not establish such a system. Thus, we used an in vivo method to transform immature T-cells by inducing thymomas with the v-abl expressing Abelson murine leukemia virus (A-MuLV). However, thymomas contained an B220+ Thy-1lo population, which expressed an early lymphoid phenotype. The B220+ Thy-1lo thymoma cells also did not rearrange TCR or Igk genes, but contained a subpopulation of early B-cells that rearranged Igh genes. However, in 6 of 13 tumors, 40-70% of the B220+ Thy-1lo thymoma cells did not rearrange Igh genes, and appear to represent undifferentiated lymphoid progenitors.

We next sought to identify the thymic target population that gave rise to the B220+ Thy-1lo undifferentiated lymphoid progenitors. Since the B220+ Thy-1lo thymoma population phenotypically resembled the B220+ Thy-1lo bone marrow population that is the preferential population phenotypically resembled the B220+ Thy-1lo bone marrow population that is the preferential A-MuLV transformation target in vitro, we tested the hypothesis that the normal thymus also contains B220+ Thy-1lo cells that are highly susceptible to in vitro A-MuLV transformation. Although B220+ cells (1/3 of which were Thy-1lo) were found in the thymus, thymic B220+ cells were unlike marrow B220+ cells since they were not susceptible to in vitro A-MuLV transformation and were not enriched with actively cycling cells. Therefore, thymic B220+ cells likely do not contain the target that gives rise to the undifferentiated lymphoid progenitors.

Finally, we started examining how the ABL oncogenes may interfere with early B-lymphopoiesis. v-abl transformed pre-B cell lines typically can not rearrange Ig light chain genes since the v-abl kinase actively suppresses RAG expression and NF-kb activity. BCR-ABL transformed pre-B cells commonly do not rearrange Igk light chain genes also; therefore, we hypothesized that v-abl and BCR-ABL may utilize similar mechanisms to arrest Ig light chain assembly. We found that BCR-ABL kinase activity is necessary for RAG inhibition; however, kinase activity is not sufficient for RAG suppression since other BCR-ABL domains are also involved.

 
Thesis Publications

  • Chen EY, Swanson BJ, Clark SS. Transformation of undifferentiated Thy-1 B220+ thymic lymphoid cells by the Abelson murine leukemia virus. Dev Immunol 8:1-18, 2000.